Back to Insider Trading View Full Company Profile

CRBP

MODERATE

Corbus Pharmaceuticals Holdings, Inc.

CIK: 0001595097

Strong Sell (70% confidence)

Last activity: Mar 2, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $4.82M

Net Income -$78.54M

Total Debt $15.91M

Debt/Equity 0.11

Insider Roster (5 total, 5 active)

Insider	Sells	Net Value	Holdings
Cormorant Asset Management, LP OTHER	1	-$344K	2,344,971 shares $26.86M
Cohen Yuval Chief Executive Officer	1	-$108K	174,316 shares $1.36M
Smethurst Dominic Chief Medical Officer	2	-$77K	89,790 shares $745K
Moran Sean F. Chief Financial Officer	1	-$37K	96,694 shares $753K
Hodgson Ian Chief Operating Officer	2	-$26K	51,080 shares $377K

Recent Transactions

SELL Smethurst Dominic (Chief Medical Officer)

6,097 shares @ $8.30

$51K

Mar 2, 2026

Conviction: | View SEC Filing →

SELL Hodgson Ian (Chief Operating Officer)

847 shares @ $7.38

$6K

Feb 17, 2026

Conviction: | View SEC Filing →

SELL Cohen Yuval (Chief Executive Officer)

13,871 shares @ $7.78

$108K

Feb 13, 2026

Conviction: | View SEC Filing →

SELL Moran Sean F. (Chief Financial Officer)

4,701 shares @ $7.78

$37K

Feb 13, 2026

Conviction: | View SEC Filing →

SELL Smethurst Dominic (Chief Medical Officer)

3,285 shares @ $8.09

$27K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Hodgson Ian (Chief Operating Officer)

2,415 shares @ $8.09

$20K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Cormorant Asset Management, LP (OTHER)

30,029 shares @ $11.46

$344K

Dec 11, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.